Table 2.
Demographic characteristics of study subjects whose prescriber accepted the pharmacist recommendation to discontinue an opioid or benzodiazepine (n = 37,990).
| Characteristic | Total N | Opioid n (%) | Benzodiazepine n (%) | p Value | |
|---|---|---|---|---|---|
| Total | 22,708 (59.77) | 15,282 (40.23) | |||
| Gender | 0.2250 | ||||
| Female | 26,067 | 15,635 (59.98) | 10,432 (40.02) | ||
| Male | 11,923 | 7073 (59.32) | 4850 (40.68) | ||
| Age, years | <0.0010 | ||||
| <65 | 10,927 | 6146 (56.25) | 4781 (43.75) | ||
| 65 or older | 27,063 | 16,562 (61.20) | 10,501 (38.80) | ||
| Geographical region of prescriber | 0.0148 | ||||
| Northeast | 6804 | 4171 (61.30) | 2633 (38.70) | ||
| Midwest | 10,965 | 6540 (59.64) | 4425 (40.36) | ||
| South | 17,270 | 10,282 (59.54) | 6988 (40.46) | ||
| West | 2948 | 1713 (58.11) | 1235 (41.89) | ||
Note: Post-hoc analyses indicated a significant difference between Northeast and West regions (p = 0.0031). There was no difference between the other regions (p > 0.0083).